In: Plos one, 2012, vol. 7, no. 4, p. e35485
Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1...
|
In: Intensive Care Medicine, 2005, vol. 31, no. 11, p. 1514-1521
|
In: Intensive Care Medicine, 2009, vol. 35, no. 5, p. 903-908
|
In: Intensive Care Medicine, 2003, vol. 29, no. 7, p. 1196-1196
|
In: Clinical Infectious Diseases, 2011, vol. 52, no. 2, p. 248-256
|
In: Clinical Infectious Diseases, 2004, vol. 38, no. 3, p. 311-320
|
In: Journal of Infectious Diseases, 1994, vol. 170, no. 5, p. 1319-1322
|
In: Journal of Infectious Diseases, 2011, vol. 204, no. 9, p. 1367-1374
|
In: Medical Mycology, 2009, vol. 47, no. 6, p. 571-583
|
In: Clinical Infectious Diseases, 2009, vol. 49, no. 5, p. 733-735
|